[
  {
    "ts": null,
    "headline": "Merck & Co., Inc. (MRK) Joins BofA’s “US 1 List”",
    "summary": "Merck & Co., Inc. (NYSE:MRK) is among the most profitable healthcare stocks to buy. On January 21, TheFly reported that BofA analysts included Merck & Co., Inc. (NYSE:MRK) in its “US 1 List,” which includes the firm’s top investment ideas. A day earlier, Bernstein reiterated its Market Perform rating on Merck & Co., Inc. (NYSE:MRK), […]",
    "url": "https://finnhub.io/api/news?id=a0a17b63777b67aa8c2e548bbb0ba7f3aad149affa643d2b8ba0f068714e4ecd",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1769880946,
      "headline": "Merck & Co., Inc. (MRK) Joins BofA’s “US 1 List”",
      "id": 138316660,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MRK",
      "source": "Yahoo",
      "summary": "Merck & Co., Inc. (NYSE:MRK) is among the most profitable healthcare stocks to buy. On January 21, TheFly reported that BofA analysts included Merck & Co., Inc. (NYSE:MRK) in its “US 1 List,” which includes the firm’s top investment ideas. A day earlier, Bernstein reiterated its Market Perform rating on Merck & Co., Inc. (NYSE:MRK), […]",
      "url": "https://finnhub.io/api/news?id=a0a17b63777b67aa8c2e548bbb0ba7f3aad149affa643d2b8ba0f068714e4ecd"
    }
  },
  {
    "ts": null,
    "headline": "Alphabet, Amazon, AMD Lead Earnings Wave; Jobs Data On Deck",
    "summary": "Wall Street Week Ahead: key earnings (Amazon, Alphabet), IPOs, dividends & economic data (NFP, PMI). Read here for more details.",
    "url": "https://finnhub.io/api/news?id=b3e63802df6853657bf27d4f27978ea3f127e889b8b510bff3c097715be8804b",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1769857200,
      "headline": "Alphabet, Amazon, AMD Lead Earnings Wave; Jobs Data On Deck",
      "id": 138315868,
      "image": "https://static.seekingalpha.com/assets/og_image_1200-29b2bfe1a595477db6826bd2126c63ac2091efb7ec76347a8e7f81ba17e3de6c.png",
      "related": "MRK",
      "source": "SeekingAlpha",
      "summary": "Wall Street Week Ahead: key earnings (Amazon, Alphabet), IPOs, dividends & economic data (NFP, PMI). Read here for more details.",
      "url": "https://finnhub.io/api/news?id=b3e63802df6853657bf27d4f27978ea3f127e889b8b510bff3c097715be8804b"
    }
  },
  {
    "ts": null,
    "headline": "Assessing Guardant Health (GH) Valuation After FDA Guardant360 CDx Approval And New Merck Collaboration",
    "summary": "Guardant Health (GH) is back in focus after the FDA approved its Guardant360 CDx liquid biopsy as a companion diagnostic for BRAF V600E-mutant metastatic colorectal cancer and the company announced a multi-year collaboration with Merck. See our latest analysis for Guardant Health. These regulatory and partnership updates come after a strong run, with the latest share price at $114.04, a 30 day share price return of 11.65% and a 1 year total shareholder return of 142.74%. However, the 5 year...",
    "url": "https://finnhub.io/api/news?id=69c754e43e74610c24ffa5eef91f572e76de0673c46beb51d899c58d4ce20aba",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1769836333,
      "headline": "Assessing Guardant Health (GH) Valuation After FDA Guardant360 CDx Approval And New Merck Collaboration",
      "id": 138313015,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MRK",
      "source": "Yahoo",
      "summary": "Guardant Health (GH) is back in focus after the FDA approved its Guardant360 CDx liquid biopsy as a companion diagnostic for BRAF V600E-mutant metastatic colorectal cancer and the company announced a multi-year collaboration with Merck. See our latest analysis for Guardant Health. These regulatory and partnership updates come after a strong run, with the latest share price at $114.04, a 30 day share price return of 11.65% and a 1 year total shareholder return of 142.74%. However, the 5 year...",
      "url": "https://finnhub.io/api/news?id=69c754e43e74610c24ffa5eef91f572e76de0673c46beb51d899c58d4ce20aba"
    }
  },
  {
    "ts": null,
    "headline": "Rose's Income Garden January 2026: 3 Raises / 2 Cuts",
    "summary": "RIG portfolio up 3.44% YTD with 6.34% yield; review MRK, MPW, ARE & RC dividend changes and Rose Recommendations. Read here for a guide income investing.",
    "url": "https://finnhub.io/api/news?id=e5ddf903a1450826445876fa4860264322c9b985744d8a1d9c29d3121b4c3f52",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1769828056,
      "headline": "Rose's Income Garden January 2026: 3 Raises / 2 Cuts",
      "id": 138313564,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2217841235/image_2217841235.jpg?io=getty-c-w1536",
      "related": "MRK",
      "source": "SeekingAlpha",
      "summary": "RIG portfolio up 3.44% YTD with 6.34% yield; review MRK, MPW, ARE & RC dividend changes and Rose Recommendations. Read here for a guide income investing.",
      "url": "https://finnhub.io/api/news?id=e5ddf903a1450826445876fa4860264322c9b985744d8a1d9c29d3121b4c3f52"
    }
  }
]